CD38 and B-cell chronic lymphocytic leukemia: Both markers are highly expressed in IGHV-UM CLL and their over-expression is associated with poor diagnosis and shorter time to treatment and survival, although the correlation with the aggressiveness of the disease and resistance to therapy is more pronounced for CLL expressing Zap-70, than for those with high level of CD38 whose expression vary over time [8, 9].